7.80 USD
▲-0.24+1.43%
盘后 7.63 -0.78%
2026-08-03
市值
$397.02M
市盈率
16.30
EPS
0.48
股息率
—
52 周区间
3.04 – 8.75
成交量
269.41K
Beta
1.19
目标价
—
52W 低 3.0452W 高 8.75
价格走势
公司简介
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. The company also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breas...